Philips and Masimo partner to advance access to patient monitoring technologies
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
The FDA is beginning rulemaking to close the “adequate provision” loophole
Tagrisso plus chemotherapy achieves nearly four-year median overall survival in EGFR-mutated advanced lung cancer, setting new global standard in phase III trial
Shantived Hospital generated revenue of around Rs 50 crore in FY2025
Accelerating RNA-based therapeutic solutions for customers through co-development of products and formulation support
MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
New unit boosts innovation in liposomal delivery technologies with 8,500 MT capacity and export-ready production
The facility has been designed with a dual focus on efficiency and sustainability
Subscribe To Our Newsletter & Stay Updated